SANFORD DRUG HOUSE

SANFORD DRUG HOUSE

Creating a world of Health & Bliss

Your Health, Our Priority

Sanford Drug House is dedicated to providing exceptional pharmaceutical care and personalized service to our community. We offer a wide range of prescription medications, over-the-counter products, and health and wellness solutions to meet your needs.

Organizational Values

We strongly believe in creating a transparent Healthcare system in India. We insist in creating basic medical and drug awareness among people for their betterment and well being. People should be well informed about the positive and negative affects of the medicines they take be aware about its side effects. To create this kind of awareness, it is necessary that Pharmaceutical Companies, Doctors, Government and Patients must work together in harmony for nurturing the Society's overall Physical and Mental Health.

❤️

Humanity

Putting people first and ensuring healthcare accessibility for all.

🔍

Transparency

Maintaining open communication and clear information about our products and services.

⚕️

Medical Ethics

Upholding the highest standards of medical and pharmaceutical practices.

Our Journey

1981

Our Foundation

Sanford Drug House was founded by Mr. Balasurbramaninan B.Pharm, DHRDI with the vision of manufacturing veterinary medicines.

1982

First Product Launch

Production of B-Complex liquid under the Brand Name "Sanvit" for veterinary use, successfully marketed in Tamil Nadu and Andhra Pradesh.

1982-2003

Product Line Expansion

Expanded our veterinary medicine portfolio with products like Cokstat, Sanvit forte, Leverzine-D, Benoxy-D, Benefactor-D, Nicloben-D, Niclocide-L, and Sabala Forte.

2004

Entry into Medical Sector

Launched Wilzin, a breakthrough treatment for Wilson's Disease, available in two variants - Wilzin-25 for children and Wilzin-50 for adults, marketed throughout India.

2020

R&D in Rare Genetic Disorders

Started research and development in rare genetic liver disorders and introduced products like LIVSAL, which went on to save thousands of lives.

1 in 30,000

People affected by Wilson’s Disease worldwide

1 in 2,500

Individuals of European descent affected by Alpha-1 Antitrypsin Deficiency

6–8 years

Average time to diagnose a rare liver disorder globally

$500,000+

Estimated lifetime cost of treatment for rare liver disorders

150+

Ongoing clinical trials targeting rare genetic liver diseases (2024)